Bioactive compounds derived from microalgae showing antimicrobial activities

Journal of Aquaculture Research and Development

Volumn 5, Issue 3, 2014, Pages

  Sanmukh, Swapnil ^a   Bruno, Benedict ^a   Ramakrishnan, Udhaya ^a   Khairnar, Krishna ^a   Swaminathan, Sandhya ^a   Paunikar, Waman ^a  

^a NATIONAL ENVIRONMENTAL ENGINEERING RESEARCH INSTITUTE   (India)

Author keywords

Antibacterial; Antifungal; Antimicroalgal; Antiviral; Microalgae

Indexed keywords

EID: 84904256662     PISSN: None     EISSN: 21559546     Source Type: Journal    
DOI: 10.4172/2155-9546.1000224     Document Type: Article

References (46)

1. Tandeau-de-Marsac, HJ (1993) Adaptation of cyanobacteria to environmental stimuli: new steps towards molecular mechanisms. FEMS Microbiology Reviews 104: 119-190.
2. Blunt JW, Copp BR, Hu WP, Munro MH, Northcote PT, et al. (2008) Marine natural products. Nat Prod Rep 25: 35-94.
3. Olaizola M (2003) Commercial development of microalgal biotechnology: from the test tube to the marketplace. Biomol Eng 20: 459-466.
4. Guedes AC, Amaro HM, Malcata FX (2011) Microalgae as sources of high added-value compounds-a brief review of recent work. Biotechnol Prog 27: 597-613.
5. Mendes RL, Nobre BP, Cardoso MT, Pereira AP, Palavra AF (2003) Supercritical carbon dioxide extraction of compounds with pharmaceutical importance from microalgae. Inorganica Chimica Acta 356: 328-334.
6. Mayer AMS, Hamann MT (2005) Marine pharmacology in 2001-2002: marine compounds with antihelmintic, antibacterial, anticoagulant, antidiabetic, antifungal, anti-inflammatory, antimalarial, antiplatelet, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems and other miscellaneous mechanisms of action. Comp Biochem Physiol C Toxicol Pharmocol 140: 265-286.
7. Cardozo KHM, Guaratini T, Barros MP, Falcão VR, Tonon AP, et al. (2007) Metabolites from algae with economical impact. Comp Biochem Physiol C Toxicol Pharmacol 146: 60-78.
8. Kellan SJ, Walker JM (1989) Antibacterial activity from marine microalgae. British Journal of Phycology 23: 41-44.
9. Ozemir G, Karabay NU, Dalay MC, Pazarbasi B (2004) Antibacterial activity of volatile components and various extracts of Spirulina platensis. Phytother Res 18: 754-757.
10. Herrero M, Ibañez E, Cifuentes A, Reglero G, Santoyo S (2006) Dunaliella salina microalga pressurized liquid extracts as potential antimicrobials. J Food Prot 69: 2471-2477.
11. Ghasemi Y, Yazdi MT, Shafiee A, Amini M, Shokravi S, et al. (2004) Parsiguine, a novel antimicrobial substance from Fischerella ambigua. Pharmaceutical Biology 42: 318-322.
12. Mendiola JA, Torres CF, Martín-Alvarez PJ, Santoyo S, Toré A, et al. (2007) Use of supercritical CO2 to obtain extracts with antimicrobial activity from Chaetoceros muelleri microalga. A correlation with their lipidic content. Eur Food Res Technol 224: 505-510.
13. Metting B, Pyne JW (1986) Biologically active compounds from microalgae. Enzyme and Microbial Technology 8: 386-394.
14. Salem WM, Galal H, Nasr El-deen F (2011) Screening for antibacterial activities in some marine algae from the red sea (Hurghada, Egypt). African Journal of Microbiology Research 5: 2160-2167.
15. Tramper J, Battershill C, Brandenburg W, Burgess G, Hill R, et al. (2003) What to do in marine biotechnology? Biomol Eng 20: 467-471.
16. Trias J, Gordon EM (1997) Innovative approaches to novel antibacterial drug discovery. Curr Opin Biotechnol 8: 757-762.
17. Guedes AC, Barbosa CR, Amaro HM, Pereira CI, Malcata FX (2011) Microalgal and cyanobacterial cell extracts for use as natural antibacterial additives against food pathogens. International Journal of Food Science and Technology 46: 862-870.
18. Interagency Task Force on Antimicrobial Resistance (2011) 2011 Progress Towards Implementation of: A Public Health Action Plan to Combat Antimicrobial Resistance.
19. Danyal A, Mubeen U, Malik KA (2013) Investigating Two Native Algal Species to Determine Antibiotic Susceptibility Against some Pathogens. Curr Res J Biol Sci 5: 70-74
20. Akgul R, Suerdem TB, Akgul F (2013) Antimicrobial Activities of Some Marine Algae and Some Cyanobacteria from Canakkale J. Algal Biomass Utln 4: 35-40
21. Rosaline XD, Sakthivelkumar S, Rajendran K, Janarthanan S (2012) Screening of selected marine algae from the coastal Tamil Nadu, South India for antibacterial activity. Asian Pacific Journal of Tropical Biomedicine S140-S146
22. Genovese G, Faggio C, Gugliandolo C, Torre A, Spanò A, et al. (2012) In vitro evaluation of antibacterial activity of Asparagopsis taxiformis from the Straits of Messina against pathogens relevant in aquaculture. Mar Environ Res 73: 1-6.
23. Bhagavathy S, Sumathi P, Bell JS (2011) Green algae Chlorococcum humicola-a new source of bioactive compounds with antimicrobial activity. Asian Pacific Journal of Tropical Biomedicine 1: S1-S7.
24. Najdenski HM, Gigova LG, Iliev II, Pilarski PS, Lukavsky J, et al. (2013) Antibacterial and antifungal activities of selected microalgae and cyanobacteria. International Journal of Food Science and Technology 48: 1533-1540.
25. Santoyo S, Jaime L, Plaza M, Herrero M, Rodriguez-Meizoso I, et al. (2012) Antiviral compounds obtained from microalgae commonly used as carotenoid sources. Journal of Applied Phycology 24: 731-741.
26. Kim M, Yim JH, Kim SY, Kim HS, Lee WG, et al. (2012) In vitro inhibition of influenza A virus infection by marine microalga-derived sulfated polysaccharide p-KG03. Antiviral Res 93: 253-259.
27. Lee JB, Hayashi K, Hirata M, Kuroda E, Suzuki E, et al. (2006) Antiviral sulfated polysaccharide from Navicula directa, a diatom collected from deep-sea water in Toyama Bay. Biol Pharma Bull 29: 2135-2139.
28. Yim JH, Kim SJ, Ahn SH, Lee CK, Rhie KT, et al. (2004) Antiviral effects of sulfated exo-polysacchride from the marine microalga Gyrodinium impudicum strain KG03. Marine Biotechnol 6: 17-25.
29. Borowitzka MA (1995) Microalgae as sources of pharmaceuticals and other biologically active compounds. J Applied Phycol 7: 65-68.
30. Anaissie EJ, Bodey GP (1989) Nosocomial fungal infections-old problems and new challenges. Infectious Disease Clinics of North America 3: 867-882.
31. Wey SB, Mori M, Pfaller M, Woolson RF, Wenzel RP (1988) Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch Intern Med 148: 2642-2645.
32. Sánchez F, Fernández JM, Acien FG, Rueda A, Perez-Parra J, et al. (2008) Influence of culture conditions on the productivity and lutein content of the new strain Scenedesmus almeriensis. Process Biochemistry 43: 398-405.
33. Santoyo S, Rodríguez-Meizoso I, Cifuentes A, Jaime L, García-Blairsy Reina G, et al. (2009) Green processes based on the extraction with pressurized fluids to obtain potent antimicrobials from Haematococcus pluvialis microalgae. LWT-Food Science and Technology 42: 1213-1218.
34. Bagchi SN, Palod A, Chauhan VS (1990) Algicidal properties of a bloomforming blue-green alga, Oscillatoria sp. J Basic Microbiol 30: 21-29.
35. Yingying S, Changhai W, Jing C (2008) Growth inhibition of eight species of microalgae by growth inhibitor from the culture of Isochrysis galbana and its isolation and identification. J Appl Phycol 20: 315-321.
36. Pratt R (1942) Studies on Chlorella vulgaris. V. Some properties of the growthinhibitor formed by Chlorella cells. Amer J Bot 29: 142-148.
37. Hellebust JA (1974) Extracellular products: Algal Physiology and Biochemistry. (Stewart WDP edn), University of California Press, Oxford, 838-863.
38. Vonthron-Sénécheau C, Kaiser M, Devambez I, Vastel A, Mussio I, et al. (2011) Antiprotozoal Activities of Organic Extracts from French Marine Seaweeds. Mar Drugs 9: 922-933.
39. Spavieri J, Kaiser M, Casey R, Hingley-Wilson S, Lalvani A, et al. (2010) Antiprotozoal, antimycobacterial and cytotoxic potential of some british green algae. Phytother Res 24: 1095-1098.
40. Cantillo-Ciau Z, Moo-Puc R, Quijano L, Freile-Pelegrín Y (2010) The Tropical Brown Alga Lobophora variegata: A Source of Antiprotozoal Compounds. Marine Drugs 8: 1292-1304.
41. Orhan I, Sener B, Atici T, Brun R, Perozzo R, et al. (2014) Turkish freshwater and marine macrophyte extracts show in vitro antiprotozoal activity and inhibit FabI, a key enzyme of Plasmodium falciparum fatty acid biosynthesis. The Free Library.
42. Leon-Deniz LV, Dumonteil E, Moo-Puc R, Freile-Pelegrin Y (2009) Antitrypanosomal in vitro activity of tropical marine algae extracts. Pharmaceutical Biology 47: 864-871.
43. Afolayana AF, Boltonb JJ, Lateganc CA, Smithc PJ, Beukesa DR (2008) Fucoxanthin, Tetraprenylated Toluquinone and Toluhydroquinone Metabolites from Sargassum heterophyllum Inhibit the in vitro Growth of the Malaria Parasite Plasmodium falciparum. Z Naturforsch C 63: 848-852.
44. Govenkar MB, Wahidulla S (2000) Constituents of Chondria armata. Phytochem 54: 979-81.
45. Khanavi M, Toulabi PB, Abai MR, Sadati N, Hadjiakhoondi F, et al. (2011) Larvicidal activity of marine algae, Sargassum swartzii and Chondria dasyphylla, against malaria vector Anopheles stephensi. J Vector Borne Dis 48: 241-244.
46. Afolayan AF, Mann MG, Lategan CA, Smith PJ, Bolton JJ, et al. (2009) Antiplasmodial halogenated monoterpenes from the marine red alga Plocamium cornutum. Phytochemistry 70: 597-600.